521 related articles for article (PubMed ID: 16735673)
1. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
Kong Y; Tannous P; Lu G; Berenji K; Rothermel BA; Olson EN; Hill JA
Circulation; 2006 Jun; 113(22):2579-88. PubMed ID: 16735673
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.
Kee HJ; Sohn IS; Nam KI; Park JE; Qian YR; Yin Z; Ahn Y; Jeong MH; Bang YJ; Kim N; Kim JK; Kim KK; Epstein JA; Kook H
Circulation; 2006 Jan; 113(1):51-9. PubMed ID: 16380549
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
[TBL] [Abstract][Full Text] [Related]
5. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
[TBL] [Abstract][Full Text] [Related]
6. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy.
Kee HJ; Eom GH; Joung H; Shin S; Kim JR; Cho YK; Choe N; Sim BW; Jo D; Jeong MH; Kim KK; Seo JS; Kook H
Circ Res; 2008 Nov; 103(11):1259-69. PubMed ID: 18849323
[TBL] [Abstract][Full Text] [Related]
7. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats.
Bogaard HJ; Mizuno S; Hussaini AA; Toldo S; Abbate A; Kraskauskas D; Kasper M; Natarajan R; Voelkel NF
Am J Respir Crit Care Med; 2011 May; 183(10):1402-10. PubMed ID: 21297075
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure.
Gallo P; Latronico MV; Gallo P; Grimaldi S; Borgia F; Todaro M; Jones P; Gallinari P; De Francesco R; Ciliberto G; Steinkühler C; Esposito G; Condorelli G
Cardiovasc Res; 2008 Dec; 80(3):416-24. PubMed ID: 18697792
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II induces cardiomyocyte hypertrophy probably through histone deacetylases.
Lu Y; Yang S
Tohoku J Exp Med; 2009 Sep; 219(1):17-23. PubMed ID: 19713680
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.
Chen Y; Du J; Zhao YT; Zhang L; Lv G; Zhuang S; Qin G; Zhao TC
Cardiovasc Diabetol; 2015 Aug; 14():99. PubMed ID: 26245924
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.
Kang SH; Seok YM; Song MJ; Lee HA; Kurz T; Kim I
Mol Pharmacol; 2015 May; 87(5):782-91. PubMed ID: 25667225
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of histone deacetylase on ventricular remodeling in infarcted rats.
Lee TM; Lin MS; Chang NC
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H968-77. PubMed ID: 17400721
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy.
Raghunathan S; Goyal RK; Patel BM
Can J Physiol Pharmacol; 2017 Mar; 95(3):260-267. PubMed ID: 28177689
[TBL] [Abstract][Full Text] [Related]
14. MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.
Fournel M; Bonfils C; Hou Y; Yan PT; Trachy-Bourget MC; Kalita A; Liu J; Lu AH; Zhou NZ; Robert MF; Gillespie J; Wang JJ; Ste-Croix H; Rahil J; Lefebvre S; Moradei O; Delorme D; Macleod AR; Besterman JM; Li Z
Mol Cancer Ther; 2008 Apr; 7(4):759-68. PubMed ID: 18413790
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
Duan H; Heckman CA; Boxer LM
Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
[TBL] [Abstract][Full Text] [Related]
16. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
Alcendor RR; Kirshenbaum LA; Imai S; Vatner SF; Sadoshima J
Circ Res; 2004 Nov; 95(10):971-80. PubMed ID: 15486319
[TBL] [Abstract][Full Text] [Related]
17. HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.
Renaud L; Harris LG; Mani SK; Kasiganesan H; Chou JC; Baicu CF; Van Laer A; Akerman AW; Stroud RE; Jones JA; Zile MR; Menick DR
Circ Heart Fail; 2015 Nov; 8(6):1094-104. PubMed ID: 26371176
[TBL] [Abstract][Full Text] [Related]
18. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H
Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by Phenylephrine.
Zhao Z; Lv J; Guo N; Guo Q; Zeng S; Fang Y; Chen W; Wang Z
Curr Drug Targets; 2023; 24(4):371-378. PubMed ID: 36734909
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors.
Antos CL; McKinsey TA; Dreitz M; Hollingsworth LM; Zhang CL; Schreiber K; Rindt H; Gorczynski RJ; Olson EN
J Biol Chem; 2003 Aug; 278(31):28930-7. PubMed ID: 12761226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]